Log In
Friday 22nd June 2018

Cystic fibrosis drug hope

10th September 2008

Researchers from the University of Bristol have shown that an experimental drug is proving effective for treating the genetic disease cystic fibrosis (CF).

While existing treatments only ease symptoms of CF such as the sticky mucus that clogs the lungs, the new drug VX-770 restores function to defective proteins which cause the disease.

More clinical trials are needed to find out how many patients may benefit but scientists says the results with VX-770 suggest drug therapies which target defects at the root of the disease have the potential to improve the quality of life of CF patients.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2018